The new coronavirus epidemic in 2020 has made in vitro diagnosis (IVD) a medical professional word into the homes of ordinary people. Compared with biochemical diagnosis and immune diagnosis, molecular diagnosis, with its advantages of short detection time, higher sensitivity and stronger specificity, has quickly become the fastest growing segment track in the field of IVD in China, driven by the needs of precision medicine and personalized treatment. From the technical point of view, the field of molecular diagnostics mainly includes PCR (traditional PCR, qPCR and dPCR), fluorescence in situ hybridization (FISH), gene chip and the second generation of high-throughput sequencing technology (NGS), among which fluorescent PCR is the most widely used, which brings continuous demand for the downstream fluorescent dye market.

Sales in the global fluorescent dyes market reached $869.32 million in 2021 and are expected to reach $1,179.05 million in 2028, with a compound annual growth rate (CAGR) of 4.42% (2022-2028). There is a lot of uncertainty in the industry over the next few years.

At the regional level, the Chinese market has changed rapidly in the past few years, with a market size of 227.42 million US dollars in 2021, accounting for about 22.40% of the global market, and is expected to reach 320.62 million US dollars in 2028, when the global share will reach 27.19%.

Among all fluorescent dye types, organic fluorescent dyes contributed the majority of the revenue in this segment at approximately $3.1 billion, accounting for 49.93% in 2021, while other fluorescent dyes accounted for 50.07% in total. Among the downstream applications of fluorescent dyes, universities and research institutions contributed the most in this field, at $38.486 billion, accounting for 44.27 percent in 2021.